Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bionano Genomics

4.10
+0.15003.80%
Volume:132.71K
Turnover:539.03K
Market Cap:11.20M
PE:-0.03
High:4.20
Open:3.89
Low:3.80
Close:3.95
Loading ...

Stock Track | Bionano Genomics Soars 8.28% as Debt Restructuring and Lower Conversion Price Boost Investor Sentiment

Stock Track
·
01 Jan

Bionano Genomics Restructures Debt, Decreases Conversion Price

MT Newswires Live
·
01 Jan

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring That Improves Cash Runway

THOMSON REUTERS
·
01 Jan

Stock Track | Bionano Genomics Soars 7.64% Pre-Market on Promising Optical Genome Mapping Study Results

Stock Track
·
23 Dec 2024

Bionano Genomics announces publication in Modern Pathology on OGM

TIPRANKS
·
23 Dec 2024

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

GlobeNewswire
·
23 Dec 2024

Stock Track | Bionano Genomics Plummets 5.24% After Announcing Proposal for Reverse Stock Split

Stock Track
·
19 Dec 2024

Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal

GlobeNewswire
·
19 Dec 2024

Bionano Announces Presentations at the American Society of Hematology (Ash) Annual Meeting That Underscore Ogm Utility Across Blood Cancer Research and Cell & Gene Therapy

THOMSON REUTERS
·
10 Dec 2024

Hold Rating on BioNano Genomics Amid Revenue Shortfall and Strategic Shift

TIPRANKS
·
18 Nov 2024

Bionano Genomics Cut to Neutral From Buy by Ladenburg Thalmann

Dow Jones
·
16 Nov 2024

Stock Track | Bionano Genomics Plummets 5.47% on Analyst Downgrade and Restructuring Concerns

Stock Track
·
15 Nov 2024

Ladenburg downgrades Bionano Genomics on restructuring uncertainty

TIPRANKS
·
15 Nov 2024

Ladenburg Thalmann Downgrades Bionano Genomics to Neutral From Buy

MT Newswires Live
·
15 Nov 2024

Bionano Genomics downgraded to Neutral from Buy at Ladenburg

TIPRANKS
·
15 Nov 2024

Bionano Genomics Q3 Sales $6.07M Miss $7.85M Estimate

Benzinga
·
15 Nov 2024